[HTML][HTML] A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma

SJ Szefler, K Murphy, T Harper III, A Boner, I Laki… - Journal of Allergy and …, 2017 - Elsevier
Background Studies in adults and adolescents have demonstrated that tiotropium is efficacious
as an add-on therapy to inhaled corticosteroids (ICSs) with or without other maintenance …

[HTML][HTML] Infant formula with a specific blend of five human milk oligosaccharides drives the gut microbiota development and improves gut maturation markers: A …

…, A Bilev, G Vasilopoulos, S Korzynska, I Laki… - Frontiers in …, 2022 - frontiersin.org
Background: Human milk oligosaccharides (HMOs) have important biological functions for a
healthy development in early life. Objective: To investigate gut maturation effects of infant …

[HTML][HTML] Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma

C Vogelberg, M Engel, I Laki… - The Journal of …, 2018 - jaci-inpractice.org
The Global Initiative for Asthma strategy recommendations for children aged 6-11 years with
asthma include treatment with low-dose inhaled corticosteroids (ICS), followed by a …

The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis

J Laki, I Laki, K Németh, R Ujhelyi, O Bede… - International …, 2006 - academic.oup.com
Major cause of death in patients with cystic fibrosis (CF) is colonization with Staphylococcus
aureus and Pseudomonas aeruginosa. The wide phenotypic variation in CF patients …

Cell planning in mobile communication systems using SGA optimization

I Laki, L Farkas, L Nagy - EUROCON'2001. International …, 2001 - ieeexplore.ieee.org
With the imminent introduction of the 3G systems throughout the world precise cell planning
in macrocell, microcell and picocell environments have become equally important. Beside …

Relationship between breath-hold time and physical performance in patients with cystic fibrosis

M Barnai, I Laki, K Gyurkovits, L Angyan… - European Journal of …, 2005 - Springer
Rehabilitation including physiotherapy is an important part of the treatment used to help
improve the quality of life of patients with cystic fibrosis (CF). The aim of this study was to …

Late-breaking abstract: once-daily tiotropium Respimat® add-on therapy improves lung function in children with moderate symptomatic asthma

O Schmidt, E Hamelmann, C Vogelberg, I Laki… - 2016 - Eur Respiratory Soc
Background: Tiotropium Respimat ® (tioR) has been shown to improve lung function in a
Phase II study in children with moderate symptomatic asthma. Aim: To assess the efficacy of …

LATE-BREAKING ABSTRACT: Safety and tolerability of once-daily tiotropium Respimat® add-on therapy in children with moderate symptomatic asthma

C Vogelberg, I Laki, O Schmidt, E Hamelmann… - 2016 - Eur Respiratory Soc
Background: A Phase II trial has shown tiotropium Respimat ® (tioR) to be a safe and well-tolerated
bronchodilator in patients aged 6-11 years with moderate symptomatic asthma. Aim: …

Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia

…, LP James, K Kalocsai, I Koutroulis, I Laki… - The Pediatric …, 2022 - journals.lww.com
Background: Solithromycin is a new macrolide-ketolide antibiotic with potential effectiveness
in pediatric community-acquired bacterial pneumonia (CABP). Our objective was to …

[HTML][HTML] Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study

BE Sekerel, H Nell, I Laki, T Pak, E Contreras… - Clinical Drug …, 2023 - Springer
Background Indacaterol acetate (IND), a long-acting β 2 -agonist in combination with
mometasone furoate (MF), an inhaled corticosteroid (ICS), is being explored as a once-daily (od) …